en

PRODUCT DETAIL

Imreplys 250 mikrogramov prášok na injekčný roztok

Code 1178F
MA number EU/1/25/1924/001
Product Form: plv ino 5x8 ml/250 µg (liek.inj.skl.)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU
MAH, country: Partner Therapeutics Ltd., Ireland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 Immunomodulators/-stimulants
L03A Immunostimulants
L03AA Colony stimulating factors
L03AA09 Sargramostim
Shelf life: 48
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
MA issued: 21.08.2025
Validity: 21.08.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.09.2025
eu-flag.png sk-flag.png